# Comparative Evaluation of High‐Frequency Microneedling Using a Layering Technique Versus Conventional Technique for Facial Rejuvenation

**Authors:** Ye Tang, Kejia Wu, Xin Song, Zhishang Lu, Meina Fan, Manli Qiao

PMC · DOI: 10.1111/jocd.70651 · Journal of Cosmetic Dermatology · 2026-02-25

## TL;DR

This study compares two high-frequency microneedling techniques for facial rejuvenation and finds that the layering method provides better and longer-lasting results.

## Contribution

The study introduces a layering technique for high-frequency microneedling and demonstrates its superior efficacy in facial rejuvenation compared to conventional methods.

## Key findings

- The layering group showed significantly greater reduction in wrinkle and laxity scores at 1, 2, and 3 months post-treatment.
- Patient satisfaction was significantly higher in the layering group compared to the conventional group.
- The layering technique improved skin texture and elasticity more effectively and sustained these improvements over time.

## Abstract

To evaluate the effectiveness of high‐frequency microneedling (HFM) using a layering technique versus conventional HFM for facial rejuvenation, with the Fitzpatrick Wrinkle and Laxity Classification Scale (FWCS) score at 3 months post‐treatment as the primary endpoint.

A prospective non‐randomized controlled study was conducted on 30 patients undergoing facial rejuvenation at Changzhou TCM Hospital (January–December 2024), who were divided into two groups (n = 15 each). The conventional group received standard HFM, while the layered group received HFM with needle length, power, and pulse width adjusted for superficial, middle, and deep skin layers. The primary endpoint was the Fitzpatrick Wrinkle and Laxity Classification Scale (FWCS) score at 3 months post‐treatment. Secondary endpoints included FWCS scores at 1 and 2 months, VISIA‐derived skin texture/pore scores, Global Aesthetic Improvement Scale (GAIS) scores, Cutometer skin rebound rate, and patient satisfaction. Assessments were performed pre‐treatment and at 1, 2, and 3 months post‐treatment. Statistical analyses were conducted using SPSS 22.0, with linear mixed‐effects models for repeated measures, ordinal methods for GAIS, and Fisher's exact test for satisfaction.

Pre‐treatment FWCS scores showed no significant difference (p > 0.05). At 1 month, the layering group showed a significantly greater FWCS score reduction (2.53 vs. 1.34, p < 0.05). FWCS scores remained significantly lower in the layering group at 2 and 3 months (p < 0.05). Skin texture improvement was significantly better maintained in the layering group at 2 and 3 months (p < 0.05). Pore improvement was significantly better in the layering group only at 3 months (p < 0.05). GAIS scores indicated significantly superior rejuvenation effects in the layering group (p < 0.001). Patient satisfaction was significantly higher in the layering group (93.33% vs. 60.00%, p < 0.05). No serious adverse reactions occurred; transient redness and mild discomfort resolved quickly in both groups.

The HFM layering technique demonstrates superior efficacy over conventional HFM for facial rejuvenation, with more significant and sustained improvements in wrinkles, skin texture, pores, and elasticity, as well as higher patient satisfaction. Both techniques are safe, though the layered approach is associated with slightly longer downtime.

## Full-text entities

- **Genes:** ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}
- **Diseases:** pain (MESH:D010146), hyperpigmentation (MESH:D017495), skin (MESH:D012871), bacterial, fungal, or viral infections (MESH:D014777), Wrinkle (MESH:D019773), inflammation (MESH:D007249), skin flushing (MESH:D005483), pigmentation (MESH:D010859), wound infection (MESH:D014946), central nervous system disorders (MESH:D002493), edema (MESH:D004487), psychiatric disorders (MESH:D001523), keloidal (MESH:D007627), thermal injury (MESH:D020886), heart, lung and other systemic diseases (MESH:D008171), dermatitis (MESH:D003872), Laxity (MESH:D007593), facial (MESH:D005153), papular elastic tissue degeneration (MESH:C537169), elastic tissue degeneration (MESH:D009410), skin tumor (MESH:D012878), autoimmune disease (MESH:D001327), itching (MESH:D011537), infectious diseases (MESH:D003141), necrosis (MESH:D009336), erythema (MESH:D004890)
- **Chemicals:** tretinoin (MESH:D014212), FWCS (-), PA++ (MESH:D011478), glycolic acid (MESH:C031149), lidocaine (MESH:D008012), retinoids (MESH:D012176), ceramide (MESH:D002518), hyaluronic acid (MESH:D006820)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936247/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936247/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936247/full.md

---
Source: https://tomesphere.com/paper/PMC12936247